Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Pfizer acquires InnoPharma Pfizer has completed the acquisition of US-based pharmaceutical development company InnoPharma, following receipt of US regulatory approval from all government authorities required by the agreement and other closing conditions. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

Matinas submits IND for MAT9001 to treat severe hypertriglyceridemia
By PBR Staff Writer
US-based biopharmaceutical firm Matinas BioPharma Holdings has submitted an investigational new drug application (IND) for its lead drug candidate, MAT9001, to the US Food and Drug Administration (FDA) for the treatment of severe hypertriglyceridemia (TG>500mg/dL).
News
Amgen files Lawsuit against Sanofi and Regeneron for patent infringement
By PBR Staff Writer
Amgen announced that it filed a lawsuit in the United States (US) District Court of Delaware against Sanofi, Aventisub, formerly doing business as Aventis Pharmaceuticals, and Regeneron Pharmaceuticals for patent infringement of US Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
News

OTC

Cerus submits compassionate use IDE supplement for INTERCEPT Blood System treatment of ebola convalescent plasma
Cerus announced submission of a clinical protocol to the U.S. Food and Drug Administration (FDA) to make the INTERCEPT Blood System for plasma available under a Compassionate Use Investigational Device Exemption (IDE) for treatment of convalescent plasma collected from Ebola disease survivors for passive immune therapy.
News
Actavis seeks FDA approval to market Methylphenidate Hydrochloride 5mg/mL
By PBR Staff Writer
Irish pharmaceutical firm Actavis has submitted an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5mg/mL.
News

Manufacturing

Baxter introduces Hyqvia in US to treat primary immunodeficiency
By PBR Staff Writer
Baxter International and Halozyme Therapeutics have launched Hyqvia as a subcutaneous immunoglobulin treatment for adult patients with primary immunodeficiency (PI) in the US.
News
Takeda and Orexigen launch weight management drug Contrave in US
By PBR Staff Writer
Takeda Pharmaceutical and Orexigen Therapeutics have launched Contrave (naltrexone HCI and bupropion HCI) extended-release tablets in the US and will be available to patients by prescription.
News